Answer
Rifampicin decreases ivacaftor exposure (AUC) by 57% when taken with Orkambi, and co-administration is not recommended.
Sources for this answer
- Orkambi 200 mg/125 mg film coated tabletsVertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 19Document updated
Sources checked